Curated, plain-language updates on guidelines — each summarized and linked to its original source.
8 items
The ACC mourns the loss of Robert L. Frye, MD, MACC, a distinguished physician, investigator, educator and leader whose career helped shape modern cardiovascular medicine, as well as the College. Frye, who served as ACC President from 1991-1992, leaves behind a legacy of service to patients and the profession spanning more than seven decades.
Read moreA long-term follow-up of the CENTRAL and DIRECT-PLUS trials published in Circulation suggests that despite long-term weight regain, visceral fat reduction during lifestyle intervention is associated with sustained improvements in metabolic health.
Read moreThis episode of CardiaCast will feature a discussion on risk assessment and the treatment of hypertriglyceridemia.
Read moreThe global burden attributable to elevated LDL-C has grown substantially since 1990, driven largely by population growth and aging despite significant declines in age-standardized rates, according to findings from the Global Burden of Disease Study 2023 (GBD 2023) Cholesterol Collaborators published July 29 in JAMA.
Read morePatients who underwent mitral transcatheter edge-to-edge repair (M-TEER) with an optimal result were more likely to have improved hemodynamics and less likely to experience major adverse events, all-cause mortality, heart failure (HF) hospitalization or reintervention at one year
Read morePatients with low plasma renin levels had a more pronounced blood pressure (BP) reduction with spironolactone/dapagliflozin vs. dapagliflozin alone, in addition to seeing a more favorable impact on cardiovascular structure and function, while aldosterone levels exhibited no predictive value in treatment response
Read moreThe first-ever clinical practice guideline on cardiovascular-kidney-metabolic (CKM) syndrome from the American Heart Association and the American College of Cardiology details staging to assess how a person’s kidneys, metabolism
Read moreDALLAS, Dec. 16, 2025 — There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart attack, stroke, atrial fibrillation, heart failure and cardiometabolic health conditions. Effective
Read more